U.S. Markets closed
  • S&P 500

    4,185.47
    +15.05 (+0.36%)
     
  • Dow 30

    34,200.67
    +164.67 (+0.48%)
     
  • Nasdaq

    14,052.34
    +13.54 (+0.10%)
     
  • Russell 2000

    2,262.67
    +5.60 (+0.25%)
     
  • Crude Oil

    63.07
    -0.06 (-0.10%)
     
  • Gold

    1,777.30
    -2.90 (-0.16%)
     
  • Silver

    26.04
    -0.06 (-0.25%)
     
  • EUR/USD

    1.1976
    0.0000 (-0.0000%)
     
  • 10-Yr Bond

    1.5730
    +0.0430 (+2.81%)
     
  • Vix

    16.25
    -0.32 (-1.93%)
     
  • GBP/USD

    1.3831
    +0.0047 (+0.3402%)
     
  • USD/JPY

    108.8060
    +0.0900 (+0.0828%)
     
  • BTC-USD

    56,358.20
    -5,010.16 (-8.16%)
     
  • CMC Crypto 200

    1,398.97
    +7.26 (+0.52%)
     
  • FTSE 100

    7,019.53
    +36.03 (+0.52%)
     
  • Nikkei 225

    29,683.37
    +40.67 (+0.14%)
     

EU seeks to access AstraZeneca vaccines produced in U.S.- FT

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

March 6 (Reuters) - The European Union will urge the United States to permit the export of millions of doses of AstraZeneca's COVID-19 vaccine to Europe, underlining Brussels' scramble to bridge supply shortfalls, the Financial Times reported on Saturday.

The EU also wants Washington to ensure the free flow of shipments of crucial vaccine ingredients needed in European production, according to the FT.

"We trust that we can work together with the U.S. to ensure that vaccines produced or bottled in the U.S. for the fulfilment of vaccine producers' contractual obligations with the EU will be fully honoured,” the newspaper quoted the European Commission as saying. (Reporting by Ann Maria Shibu in Bengaluru Editing by Mark Heinrich)